IRIS
TORTI, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.806
EU - Europa 952
AS - Asia 107
AF - Africa 18
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 6
Totale 4.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.673
IT - Italia 342
SE - Svezia 242
GB - Regno Unito 237
CA - Canada 129
IN - India 62
DE - Germania 32
RO - Romania 19
UA - Ucraina 15
BR - Brasile 11
FR - Francia 11
A2 - ???statistics.table.value.countryCode.A2??? 9
ES - Italia 9
CN - Cina 8
NL - Olanda 7
CL - Cile 6
AU - Australia 5
EU - Europa 5
GR - Grecia 5
NG - Nigeria 5
PL - Polonia 5
FI - Finlandia 4
IE - Irlanda 4
IR - Iran 4
JP - Giappone 4
NO - Norvegia 4
TR - Turchia 4
AM - Armenia 3
HK - Hong Kong 3
IL - Israele 3
KR - Corea 3
LV - Lettonia 3
RU - Federazione Russa 3
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
IQ - Iraq 2
JO - Giordania 2
KE - Kenya 2
MD - Moldavia 2
MX - Messico 2
MY - Malesia 2
PH - Filippine 2
TZ - Tanzania 2
BD - Bangladesh 1
BE - Belgio 1
BW - Botswana 1
DZ - Algeria 1
HR - Croazia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 4.921
Salva come PNG Salva come JPEG
Città #
Chandler 904
Princeton 335
Lawrence 333
Wilmington 216
London 206
Chicago 196
Ottawa 123
Des Moines 98
Ashburn 79
Pune 34
Norwalk 32
Rome 32
Redwood City 29
Boardman 28
Catanzaro 26
Woodbridge 22
Crotone 20
Houston 19
Fairfield 17
Cosenza 13
Hanover 12
Redmond 11
Palermo 10
Settingiano 10
Milan 9
Ann Arbor 8
Rende 7
Falls Church 6
Fayetteville 6
Maryland Heights 6
Reggio Calabria 6
Naples 5
Vijayawada 5
Florence 4
Genoa 4
Helsinki 4
Monheim 4
Pisa 4
West Jordan 4
Dearborn 3
Napoli 3
Paola 3
Ricadi 3
Rosarno 3
San Francisco 3
San Mateo 3
Seattle 3
Sesto San Giovanni 3
São Paulo 3
Tappahannock 3
Voghera 3
Agrigento 2
Amman 2
Ardea 2
Augusta 2
Badalona 2
Barcelona 2
Borås 2
Cambridge 2
Caserta 2
Casoria 2
Castelfiorentino 2
Cerignola 2
Chisinau 2
Clarksburg 2
Columbia 2
Dar es Salaam 2
Denver 2
Dublin 2
Ferrara 2
Fiumicino 2
Hangzhou 2
Horia 2
Iesi 2
Kemerovo 2
Kherson 2
Kuala Lumpur 2
Labico 2
Leawood 2
Meppel 2
Minamimagome 2
Monza 2
Mountain View 2
Oslo 2
Padova 2
Petilia Policastro 2
Pizzo 2
Riga 2
Saint Louis 2
Saint-Fons 2
San Biagio di Callalta 2
Santa Clara 2
Santo Domingo 2
Senigallia 2
Siena 2
Spresiano 2
St Louis 2
Turin 2
Verona 2
Warsaw 2
Totale 3.021
Salva come PNG Salva come JPEG
Nome #
Severe hepatotoxicity during combination antiretroviral treatment: Incidence, liver histology, and outcome 88
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 64
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 34
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 33
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 32
Therapy with RAS inhibitors during the COVID-19 pandemic 32
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study 31
Virologic and resistance markers in HIV infection: rationale, state of ART and perspective in clinical practice 30
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital 30
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: The resistance and dosage adapted regimens (RADAR) study 30
Ochrobactrum anthropi 30
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 30
Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals 29
Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Higher rates of triple-class virological failure in perinatally HIV infected teenagers compared with heterosexually infected young adults in Europe 28
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study 28
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 28
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment 27
A king in the CASTLE? Optimum initial HIV protease inhibitor. 27
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. 27
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 27
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 27
A CASE REPORT OF SCHISTOSOMA HAEMATOBIUM INFECTION IN A PREGNANT MIGRANT RAISES CONCERNS ABOUT LACK OF SCREENING POLICIES. 27
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals 26
A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz 26
A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy 26
Evolving phenotypes of non-hospitalized patients that indicate long COVID 26
R211K and L214F ho not invariably confer high level phenotypic resistance to thymidine analogs in zidovndine-naive patients with M184V 25
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010 25
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmacoeconomic implications in a population-based setting 25
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia 25
Analysis of dominant viral populations isolated from two pediatric patients infected by HCV genotype 4. 25
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 25
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 25
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 25
Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009 24
Genetic differentiation, gene flow and the origin of infestations of the medfly, Ceratitis capitata 24
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 24
HIV-1 pharmacoresistance: clinical and therapeutic implications 24
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients 24
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 23
Current concerns in HIV antiretroviral therapy 23
Risk factors for myocardial infarction in HIV positive patients 23
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 23
A new basal subfamily of mariner elements in Ceratitis rosa and other tephritid flies 23
Prospective evaluation of bone markers, parathormone and 1,25-(OH)(2) vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz 23
HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir 23
Genotyping for guiding drug choice in human immunodeficiency virus-infected children failing multiple antiretroviral treatment regimens 23
Valutazione economica dei trattamenti anti-HIV: lo studio di coorte I.C.O.N.A. 23
Response to combination antiretroviral therapy: variation by age - The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group 23
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 23
Effectiveness of adjunctive gabapentin in resistant bipolar disorder: Is it due to anxious-alcohol abuse comorbidity? 23
Intron size polymorphism of the Adh(1) gene parallels the worldwide colonization history of the Mediterranean fruit fly, Ceratitis capitata 22
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 22
Unboosted Atazanavir for Treatment of HIV Infection Rationale and Recommendations for Use 22
Adaptive optics optical coherence tomography at 120,000 depth scans/s for non-invasive cellular phenotyping of the living human retina 22
MASTER Study Group. Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function 22
Theme 1 - Genotypic resistance tests in the management of the HIV-infected patient at virological failure 22
Mature and developing visual system of Ceratitis capitata (Diptera, Tephritidae): histochemical evidence of nitric oxide synthase in the wild type and the white eye mutant strains 22
Characterisation of viro-immunlogical responses in a closely followed cohort oh heavily pretreated patients: evidence from the GenPheRex Study 22
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort 22
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 22
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 22
Early virological failure after tenofovir plus didanosine plus efavirenz combination in HIV-positive patients upon starting antiretroviral therapy 21
Molecular characterization and chromosomal localization of female-specific genes from the Mediterranean fruit fly Ceratitis capitata (Diptera : Tephritidae) 21
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 21
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study 21
Delineating a putative phobic-anxious temperament in 126 panic-agoraphobic patients: toward a rapprochement of European and US views 21
Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts 21
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America 21
Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+T-Cell Counts >200+/mu l Despite Effective HAART 21
Challenging clinical cases in HCV infection 21
Evolution of Antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study 21
Adiponectin serum level in chronic hepatitis C infection and therapeutic profile 21
A case report of nasopharyngeal carcinoma in a Caucasian Italian man 21
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study 21
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 21
Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy 21
EVALUATION OF IL-35, AS A POSSIBLE BIOMARKER FOR FOLLOW-UP AFTER THERAPY, IN CHRONIC HUMAN SCHISTOSOMA INFECTION 20
Nucleoside analogue use before and during highly active antiretroviral therapy and virus load rebound. 20
For timing of HAART is less more? CD4(+)/CD8(+) ratio and CD4(+) percentage as surrogate markers for more complex immunological features 20
Genetic aspects of the worldwide colonization process of Ceratitis capitata 20
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 20
"Solving the puzzle" of current HAART: What key strategic trials are needed? 20
Allozyme divergence and phylogenetic relationships among species of tephritid flies 20
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients 20
Observational Study on HIV-Infected Subjects Failing HAART Receiving Tenofovir Plus Didanosine as NRTI Backbone. 20
Long-term CD4+T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 20
Is response to anti-hepatitis C virus treatment predictive of mortality in hepatitis C virus/HIV-positive patients? The Hepatitis C Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord 20
Factors influencing the normalization of CD4+T-cell count, percentage and CD4+/CD8+T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy 20
Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men 20
Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. 20
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 20
Characteristics, management, and outcomes of elderly patients with diabetes in a covid-19 unit: Lessons learned from a pilot study 20
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 19
Utility of Molecular Identification and Quantitation of Bartonella Species with Species-Specific Real-Time PCR for Monitoring Treatment Response: A Case Series. 19
Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment. 19
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitata 19
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study 19
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide 19
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy 19
Totale 2.449
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.393
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020318 0 0 0 4 27 6 11 27 23 27 62 131
2020/2021291 19 4 91 19 17 31 16 32 34 16 3 9
2021/2022880 9 3 12 236 30 17 41 216 58 104 146 8
2022/20232.588 686 110 21 276 288 245 18 161 405 170 169 39
2023/20241.024 240 149 80 79 72 291 36 24 27 26 0 0
Totale 5.101